
Hutchison China MediTech Limited HCM
$ 14.7
-2.52%
Annual report 2024
added 02-14-2026
Hutchison China MediTech Limited Total Non Current Liabilities 2011-2026 | HCM
Annual Total Non Current Liabilities Hutchison China MediTech Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 46.8 M | 32.8 M | 27.6 M | 1.12 M | 35 M | 46.4 M | 29.9 M | 2.4 M | 44.7 M | 29 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.8 M | 1.12 M | 29.6 M |
Total Non Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
40.2 M | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
409 K | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
12.2 M | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
27.3 M | - | - | $ 86.2 M | ||
|
AgeX Therapeutics
AGE
|
1.53 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
4.74 M | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
2.29 M | - | 1.93 % | $ 17.4 M | ||
|
I-Mab
IMAB
|
131 M | - | - | $ 866 M | ||
|
Aptorum Group Limited
APM
|
2.21 M | $ 0.81 | 0.15 % | $ 4.42 M | ||
|
argenx SE
ARGX
|
226 M | $ 836.39 | -0.46 % | $ 25 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
4.83 B | - | - | $ 40.3 B | ||
|
Akero Therapeutics
AKRO
|
1.52 M | - | - | $ 3.67 B | ||
|
Ascendis Pharma A/S
ASND
|
101 M | $ 234.52 | -0.2 % | $ 5 B | ||
|
Biophytis SA
BPTS
|
2.02 M | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
79.1 M | - | -0.23 % | $ 916 M | ||
|
Alterity Therapeutics Limited
ATHE
|
73.6 K | $ 3.44 | 3.42 % | $ 8.28 B | ||
|
Allena Pharmaceuticals
ALNA
|
10.2 M | - | 3.16 % | $ 1.9 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
6.39 M | - | -1.52 % | $ 24.7 M | ||
|
AlloVir
ALVR
|
5.46 M | - | 4.14 % | $ 49.1 M | ||
|
Midatech Pharma plc
MTP
|
110 K | - | -18.52 % | $ 27.3 M | ||
|
Akouos
AKUS
|
12 M | - | 0.23 % | $ 488 M | ||
|
BioVie
BIVI
|
62.5 K | $ 1.24 | -0.8 % | $ 1.83 M | ||
|
Ampio Pharmaceuticals
AMPE
|
3.53 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
106 M | - | - | $ 10.1 M | ||
|
BioMarin Pharmaceutical
BMRN
|
635 M | $ 61.58 | -1.66 % | $ 11.7 B | ||
|
Acorda Therapeutics
ACOR
|
257 M | - | -24.86 % | $ 820 K | ||
|
Atea Pharmaceuticals
AVIR
|
69.2 M | $ 4.56 | -1.94 % | $ 384 M | ||
|
Acer Therapeutics
ACER
|
244 K | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
10.2 M | - | -13.39 % | $ 1.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
541 M | - | - | - | ||
|
Applied Genetic Technologies Corporation
AGTC
|
4.15 M | - | - | $ 26.5 M | ||
|
Avenue Therapeutics
ATXI
|
2.03 M | - | -52.27 % | $ 4.45 M | ||
|
Capricor Therapeutics
CAPR
|
4.86 M | $ 28.24 | 1.18 % | $ 756 M | ||
|
Axsome Therapeutics
AXSM
|
48.9 M | $ 165.14 | -2.83 % | $ 8.22 B | ||
|
Ayala Pharmaceuticals
AYLA
|
553 K | - | - | $ 7.46 M | ||
|
CASI Pharmaceuticals
CASI
|
38.2 M | $ 0.31 | -61.59 % | $ 42.2 M | ||
|
Atreca
BCEL
|
12.6 M | - | -11.76 % | $ 5.79 M | ||
|
Alpine Immune Sciences
ALPN
|
15.9 M | - | - | $ 2.17 B | ||
|
BioDelivery Sciences International
BDSI
|
78.7 M | - | -4.8 % | $ 255 M | ||
|
Catalyst Biosciences
CBIO
|
981 K | $ 12.21 | -3.48 % | $ 804 M | ||
|
Aeterna Zentaris
AEZS
|
19.1 M | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
374 M | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
9.03 B | $ 191.78 | -1.72 % | $ 28.1 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
48 M | - | -9.72 % | $ 5.89 M | ||
|
Baudax Bio
BXRX
|
65.4 M | - | 0.59 % | $ 63 K | ||
|
Aptose Biosciences
APTO
|
10.2 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
114 K | - | -39.0 % | $ 4.57 M | ||
|
Aridis Pharmaceuticals
ARDS
|
854 K | - | 17.91 % | $ 11.1 M | ||
|
BioNTech SE
BNTX
|
341 M | $ 110.5 | -0.35 % | $ 27.2 B | ||
|
Amneal Pharmaceuticals
AMRX
|
2.42 B | $ 14.64 | -0.17 % | $ 4.52 B |